Aberdeen Asset Management’s Xylem XYL Stock Holding History

Aberdeen Asset Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.72M	Sell	31,087 -2,671	-8%	-$139K	0.01%	619
2017 Q1	$1.7M	Buy	33,758 +3,133	+10%	+$153K	0.01%	609
2016 Q4	$1.52M	Sell	30,625 -1,718	-5%	-$87.1K	0.01%	607
2016 Q3	$1.7M	Buy	32,343 +79	+0.2%	+$3.87K	0.01%	593
2016 Q2	$1.44M	Sell	32,264 -368	-1%	-$16K	0.01%	600
2016 Q1	$1.33M	Sell	32,632 -2,726	-8%	-$100K	﹤0.01%	603
2015 Q4	$1.26M	Buy	35,358 +7,040	+25%	+$255K	﹤0.01%	611
2015 Q3	$930K	Sell	28,318 -245	-0.9%	-$8.24K	﹤0.01%	597
2015 Q2	$1.06M	Sell	28,563 -756	-3%	-$27.5K	﹤0.01%	594
2015 Q1	$1.03M	Sell	29,319 -2,643	-8%	-$93.2K	﹤0.01%	604
2014 Q4	$1.22M	Sell	31,962 -21,357	-40%	-$781K	﹤0.01%	598
2014 Q3	$1.89M	Sell	53,319 -3,068	-5%	-$114K	﹤0.01%	629
2014 Q2	$2.2M	Buy	56,387 +39,322	+230%	+$1.47M	﹤0.01%	624
2014 Q1	$621K	Sell	17,065 -600	-3%	-$21.9K	﹤0.01%	538
2013 Q4	$607K	Hold	17,665	–	–	﹤0.01%	525
2013 Q3	$493K	Hold	17,665	–	–	﹤0.01%	537
2013 Q2	$476K	Buy	+17,665	New	+$488K	﹤0.01%	536

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Aberdeen Asset Management's XYL Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Xylem (XYL) stake by 7.9% in Q2 2017, selling an estimated $139K and leaving 31,087 shares worth $1.72M. The position accounts for 0.01% of the portfolio, ranked #619.

Aberdeen Asset Management first reported a position in XYL in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.2M in Q2 2014. 550 funds tracked by Wall St. Rank hold XYL as of Q2 2017.

Aberdeen Asset Management held 31,087 shares of Xylem worth $1.72M as of Q2 2017.
Aberdeen Asset Management sold 2,671 Xylem shares in Q2 2017, an estimated $139K.
Xylem made up 0.01% of Aberdeen Asset Management's portfolio in Q2 2017, its #619 holding.
Aberdeen Asset Management first reported a position in Xylem in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Xylem position peaked at $2.2M in Q2 2014.
550 funds tracked by Wall St. Rank held Xylem as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.